vs
Side-by-side financial comparison of EverQuote, Inc. (EVER) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
EverQuote, Inc. is the larger business by last-quarter revenue ($190.9M vs $164.7M, roughly 1.2× PTC THERAPEUTICS, INC.). EverQuote, Inc. runs the higher net margin — 9.8% vs -82.0%, a 91.7% gap on every dollar of revenue. On growth, EverQuote, Inc. posted the faster year-over-year revenue change (14.5% vs -22.7%). Over the past eight quarters, EverQuote, Inc.'s revenue compounded faster (27.6% CAGR vs -11.5%).
EverQuote, Inc. is an online insurance marketplace founded in 2011 and based in Cambridge, Massachusetts.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
EVER vs PTCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $190.9M | $164.7M |
| Net Profit | $18.7M | $-135.0M |
| Gross Margin | 97.8% | — |
| Operating Margin | 12.3% | -43.3% |
| Net Margin | 9.8% | -82.0% |
| Revenue YoY | 14.5% | -22.7% |
| Net Profit YoY | 133.7% | -104.8% |
| EPS (diluted) | $0.51 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $190.9M | — | ||
| Q4 25 | $195.3M | $164.7M | ||
| Q3 25 | $173.9M | $211.0M | ||
| Q2 25 | $156.6M | $178.9M | ||
| Q1 25 | $166.6M | $1.2B | ||
| Q4 24 | $147.5M | $213.2M | ||
| Q3 24 | $144.5M | $196.8M | ||
| Q2 24 | $117.1M | $186.7M |
| Q1 26 | $18.7M | — | ||
| Q4 25 | $57.8M | $-135.0M | ||
| Q3 25 | $18.9M | $15.9M | ||
| Q2 25 | $14.7M | $-64.8M | ||
| Q1 25 | $8.0M | $866.6M | ||
| Q4 24 | $12.3M | $-65.9M | ||
| Q3 24 | $11.6M | $-106.7M | ||
| Q2 24 | $6.4M | $-99.2M |
| Q1 26 | 97.8% | — | ||
| Q4 25 | 97.7% | — | ||
| Q3 25 | 97.3% | — | ||
| Q2 25 | 96.9% | — | ||
| Q1 25 | 96.8% | — | ||
| Q4 24 | 96.3% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 95.7% | — |
| Q1 26 | 12.3% | — | ||
| Q4 25 | 9.5% | -43.3% | ||
| Q3 25 | 10.1% | 1.4% | ||
| Q2 25 | 9.0% | -19.5% | ||
| Q1 25 | 4.8% | 82.5% | ||
| Q4 24 | 8.2% | -76.2% | ||
| Q3 24 | 8.1% | -27.7% | ||
| Q2 24 | 5.4% | -21.5% |
| Q1 26 | 9.8% | — | ||
| Q4 25 | 29.6% | -82.0% | ||
| Q3 25 | 10.8% | 7.5% | ||
| Q2 25 | 9.4% | -36.3% | ||
| Q1 25 | 4.8% | 73.7% | ||
| Q4 24 | 8.3% | -30.9% | ||
| Q3 24 | 8.0% | -54.2% | ||
| Q2 24 | 5.5% | -53.1% |
| Q1 26 | $0.51 | — | ||
| Q4 25 | $1.53 | $-1.63 | ||
| Q3 25 | $0.50 | $0.20 | ||
| Q2 25 | $0.39 | $-0.83 | ||
| Q1 25 | $0.21 | $10.04 | ||
| Q4 24 | $0.35 | $-0.85 | ||
| Q3 24 | $0.31 | $-1.39 | ||
| Q2 24 | $0.17 | $-1.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $178.5M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $240.9M | $-205.3M |
| Total Assets | $324.0M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $178.5M | — | ||
| Q4 25 | $171.4M | $1.9B | ||
| Q3 25 | $145.8M | $1.7B | ||
| Q2 25 | $148.2M | $2.0B | ||
| Q1 25 | $125.0M | $2.0B | ||
| Q4 24 | $102.1M | $1.1B | ||
| Q3 24 | $82.8M | $1.0B | ||
| Q2 24 | $60.9M | $1.1B |
| Q1 26 | $240.9M | — | ||
| Q4 25 | $238.0M | $-205.3M | ||
| Q3 25 | $174.9M | $-155.8M | ||
| Q2 25 | $170.3M | $-206.5M | ||
| Q1 25 | $149.5M | $-185.8M | ||
| Q4 24 | $135.4M | $-1.1B | ||
| Q3 24 | $117.7M | $-1.1B | ||
| Q2 24 | $100.8M | $-980.2M |
| Q1 26 | $324.0M | — | ||
| Q4 25 | $326.9M | $2.9B | ||
| Q3 25 | $256.1M | $2.6B | ||
| Q2 25 | $241.4M | $2.6B | ||
| Q1 25 | $232.1M | $2.7B | ||
| Q4 24 | $210.5M | $1.7B | ||
| Q3 24 | $180.5M | $1.8B | ||
| Q2 24 | $158.0M | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.6M | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | 1.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $29.6M | — | ||
| Q4 25 | $27.0M | $-34.3M | ||
| Q3 25 | $19.8M | $-66.3M | ||
| Q2 25 | $25.3M | $-58.3M | ||
| Q1 25 | $23.3M | $870.1M | ||
| Q4 24 | $20.1M | $-30.0M | ||
| Q3 24 | $23.6M | $-77.0M | ||
| Q2 24 | $12.4M | $-71.5M |
| Q1 26 | — | — | ||
| Q4 25 | $25.8M | $-36.6M | ||
| Q3 25 | $18.5M | $-69.7M | ||
| Q2 25 | $23.8M | $-59.6M | ||
| Q1 25 | $22.2M | $868.4M | ||
| Q4 24 | $19.1M | $-33.8M | ||
| Q3 24 | $22.1M | $-77.5M | ||
| Q2 24 | $11.5M | $-78.8M |
| Q1 26 | — | — | ||
| Q4 25 | 13.2% | -22.3% | ||
| Q3 25 | 10.6% | -33.1% | ||
| Q2 25 | 15.2% | -33.3% | ||
| Q1 25 | 13.3% | 73.8% | ||
| Q4 24 | 13.0% | -15.8% | ||
| Q3 24 | 15.3% | -39.4% | ||
| Q2 24 | 9.8% | -42.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.6% | 1.4% | ||
| Q3 25 | 0.7% | 1.6% | ||
| Q2 25 | 0.9% | 0.7% | ||
| Q1 25 | 0.7% | 0.1% | ||
| Q4 24 | 0.7% | 1.8% | ||
| Q3 24 | 1.0% | 0.3% | ||
| Q2 24 | 0.7% | 4.0% |
| Q1 26 | 1.59× | — | ||
| Q4 25 | 0.47× | — | ||
| Q3 25 | 1.05× | -4.17× | ||
| Q2 25 | 1.72× | — | ||
| Q1 25 | 2.92× | 1.00× | ||
| Q4 24 | 1.64× | — | ||
| Q3 24 | 2.04× | — | ||
| Q2 24 | 1.93× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EVER
| Automotive | $172.4M | 90% |
| Home and renters | $18.5M | 10% |
PTCT
Segment breakdown not available.
